Permira Advisers is a private equity firm specializing in mature, emerging growth, industry consolidation, growth capital, expansion financing, restructuring, financial acquisitions, leveraged buyouts, buyings, and growth buyouts. The firm seeks to invest in medium to large companies in the chemicals, consumers, industrial products and services, technology, media, recruitment, fitness, and telecommunications (TMT), financial services, trade, life sciences, and healthcare. For industrial products and services sector, it makes investments in purchase of non-core operations; public-to-private acquisitions of listed companies orphaned by the market or seeking to dramatically develop or restructure away from public markets; purchase of private companies looking to transition their ownership, expand their capital base, or make value changing acquisitions; minority positions with partners; and business services and capital goods. Within consumer sector, the firm focuses on consumer products, food and beverage, leisure, luxury goods, and retail. In industrial products and services, it targets automotive, utilities and infrastructure, transportation and logistics, manufacturing, paper and packaging, construction and building technology, metal and mining, and business services. For technology sector, the firm prefers to invest in semiconductors, electronics and instrumentation, software and information technology services, and telecom equipment including fixed network, mobile network, and handsets. In media, it focuses on broadcasting, professional publishing, consumer publishing, online commerce vendors, content production and distribution companies, and advertising and marketing services. Within telecommunications, the firm seeks to invest in satellite services, mobile telecommunications, fixed telecommunications, and cable. In financial services, it invests in asset and wealth management, P&C insurance, financial infrastructure, and services sectors. In healthcare, the firm typically invests in generics, specialty pharmaceuticals, CMOs, consumer-facing medical technology businesses, and diagnostic companies. The firm also seeks to invest in content development, fashion, and design.